8-K filed March 21, 2023, 7:59 PM ET ticker PURE CIK 0001006028

leadership confidence high sentiment neutral materiality 0.60

Pure Bioscience names Robert Bartlett CEO; Tom Lee resigns, stays on Board

PURE BIOSCIENCE, INC.

Tom Y. Lee resigned as President and CEO effective March 15, 2023; will continue on Board.
Robert Bartlett, Board member since Feb 2023, appointed President and CEO; base salary $300k, sign-on $17.5k.
Bartlett granted option to purchase 500k shares, vesting quarterly over one year.
Tom Myers transitioned from COO to EVP Technology and Development; remains on Board.
Kristin A. Taylor resigned from Board effective March 19, 2023; no disagreement.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Robert Bartlett

President and Chief Executive Officer

PURE · PURE BIOSCIENCE, INC.

Effective: 2023-03-15
Filed: March 21, 2023, 7:59 PM ET

the Board appointed Robert Bartlett, a member of the Board, as the Company’s President and Chief Executive Officer, effective as of the Effective Date.

Role change

Tom Myers

Executive Vice President, Technology and Development

PURE · PURE BIOSCIENCE, INC.

Effective: 2023-03-15
Filed: March 21, 2023, 7:59 PM ET

Tom Myers, the Company’s Chief Operating Officer and member of the Board, resigned as the Company’s Chief Operating Officer in connection with his transition to the Company’s Executive Vice President, Technology and Development, each effective as of the Effective Date.

Departed

Kristin A. Taylor

Director

PURE · PURE BIOSCIENCE, INC.

Effective: 2023-03-19
Filed: March 21, 2023, 7:59 PM ET

On March 19, 2023, Kristin A. Taylor delivered notice to the Board of her resignation from the Board, effective March 19, 2023.

Departed

Tom Y. Lee

President and Chief Executive Officer

PURE · PURE BIOSCIENCE, INC.

Effective: 2023-03-15
Successor: Robert Bartlett
Filed: March 21, 2023, 7:59 PM ET

Tom Y. Lee, the President, Chief Executive Officer and member of the Board of Directors (the “Board”) of Pure Bioscience, Inc. (the “Company”), resigned as the Company’s President and Chief Executive Officer, effective as of the Effective Date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert Bartlett was appointed as President and Chief Executive Officer at PURE BIOSCIENCE, INC..

Action: appointed
Role: President and Chief Executive Officer

Exact text from the filing

the Board appointed Robert Bartlett, a member of the Board, as the Company’s President and Chief Executive Officer, effective as of the Effective Date.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Tom Myers departed as Executive Vice President, Technology and Development at PURE BIOSCIENCE, INC..

Action: resigned as COO and transitioned to EVP
Role: Executive Vice President, Technology and Development

Exact text from the filing

Tom Myers, the Company’s Chief Operating Officer and member of the Board, resigned as the Company’s Chief Operating Officer in connection with his transition to the Company’s Executive Vice President, Technology and Development, each effective as of the Effective Date.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Kristin A. Taylor resigned as Director at PURE BIOSCIENCE, INC..

Action: resigned
Role: Director

Exact text from the filing

On March 19, 2023, Kristin A. Taylor delivered notice to the Board of her resignation from the Board, effective March 19, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Tom Y. Lee resigned as President and Chief Executive Officer at PURE BIOSCIENCE, INC..

Action: resigned
Role: President and Chief Executive Officer

Exact text from the filing

Tom Y. Lee, the President, Chief Executive Officer and member of the Board of Directors (the “Board”) of Pure Bioscience, Inc. (the “Company”), resigned as the Company’s President and Chief Executive Officer, effective as of the Effective Date.

View on SEC.gov

PURE BIOSCIENCE, INC. filing history →

Source: SEC EDGAR

accession 0001493152-23-008364

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.